Sfoglia per Autore
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research
2011-01-01 Bonomi, M; Pilotto, Sara; Milella, M; Massari, F; Cingarlini, Sara; Brunelli, Matteo; Chilosi, Marco; Tortora, Giampaolo; Bria, Emilio
Sorafenib for lung cancer: is the "Battle" still open ?
2012-01-01 Bria, Emilio; Pilotto, Sara; Tortora, Giampaolo
Clinical meta-analyses of targeted therapies in adenocarcinoma.
2013-01-01 Bria, Emilio; Bonomi, M; Pilotto, Sara; Massari, F; Novello, S; Levra, Mg; Tortora, Giampaolo; Scagliotti, G.
Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number.
2013-01-01 Pilotto, Sara; Bria, Emilio; Peretti, U; Massari, F; Garassino, M; Pelosi, G; Tortora, Giampaolo
Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.
2013-01-01 Vari, S.; Pilotto, Sara; Maugeri Saccà, M.; Ciuffreda, L.; Incani, U. C.; Falcone, I.; Curatolo, A. D.; Ceribelli, A.; Gelibter, A.; Maria, R. D.; Tortora, Giampaolo; Cognetti, F.; Bria, Emilio; Milella, M.
Predictors of outcome for EGFR‑mutant non-small-cell lung cancer treated with first-line tyrosine kinase inhibitors.
2013-01-01 Pilotto, S.; Bria, E.
Neoplasie a sede primitiva ignota (Capitolo 18)
2013-01-01 Bria, Emilio; Massari, F; Pilotto, Sara; Maines, F; Tortora, Giampaolo
PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine.
2013-01-01 Pilotto, Sara; Peretti, U; Novello, S; Rossi, G; Milella, M; Giaj Levra, M; Ciuffreda, L; Massari, F; Brunelli, M; Tortora, Giampaolo; Bria, Emilio
Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: A 'Hard Days Night'
2014-01-01 Pilotto, Sara; Bonomi, M; Massari, F; Milella, M; Ciuffreda, L; Brunelli, Matteo; Fassan, M; Chilosi, Marco; Scarpa, Aldo; Tortora, Giampaolo; Bria, Emilio
Targeting the epidermal growth factor receptor in solid tumors: focus on safety.
2014-01-01 Lucchini, E; Pilotto, Sara; Spada, E; Melisi, Davide; Bria, Emilio; Tortora, Giampaolo
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials
2014-01-01 Bria, Emilio; Carbognin, L; Furlanetto, J; Pilotto, Sara; Bonomi, M; Guarneri, V; Vicentini, C; Brunelli, Matteo; Nortilli, R; Pellini, Francesca; Sperduti, I; Giannarelli, D; Pollini, Giovanni Paolo; Conte, P; Tortora, Giampaolo
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer.
2014-01-01 Bria, Emilio; Di Modugno, F; Sperduti, I; Iapicca, P; Visca, P; Alessandrini, G; Antoniani, B; Pilotto, Sara; Ludovini, V; Vannucci, J; Bellezza, G; Sidoni, A; Tortora, Giampaolo; Radisky, Dc; Crinò, L; Cognetti, F; Facciolo, F; Mottolese, M; Milella, M; Nisticò, P.
Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials
2014-01-01 Pilotto, Sara; Di Maio, M; Peretti, U; Kinspergher, S; Brunelli, Matteo; Massari, F; Sperduti, I; Giannarelli, D; De Marinis, F; Tortora, Giampaolo; Bria, Emilio
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung
2014-01-01 Caliò, A; Nottegar, Alessia; Gilioli, Eliana; Bria, Emilio; Pilotto, Sara; Peretti, U; Kinspergher, S; Simionato, F; Pedron, Serena; Knuutila, S; Tortora, Giampaolo; Eccher, Albino; Santo, A; Tondulli, L; Inghirami, G; Tabbò, F; Martignoni, Guido; Chilosi, Marco; Scarpa, Aldo; Brunelli, Matteo
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers
2014-01-01 Fassan, M; Simbolo, Michele; Bria, Emilio; Mafficini, A; Pilotto, Sara; Capelli, Paola; Bencivenga, M; Pecori, Sara; Luchini, Claudio; Neves, D; Turri, G; Vicentini, C; Montagna, Licia; Tomezzoli, Anna; Tortora, Giampaolo; Chilosi, Marco; DE MANZONI, Giovanni; Scarpa, Aldo
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
2015-01-01 Carbognin, Luisa; Pilotto, Sara; Milella, Michele; Vaccaro, Vanja; Brunelli, Matteo; Calio', Anna; Cuppone, Federica; Sperduti, Isabella; Giannarelli, Diana; Chilosi, Marco; Bronte, Vincenzo; Scarpa, Aldo; Bria, Emilio; Tortora, Giampaolo
Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity
2015-01-01 Pilotto, Sara; Molina Vila, Miguel Angel; Karachaliou, Niki; Carbognin, Luisa; Viteri, Santiago; González Cao, Maria; Bria, Emilio; Tortora, Giampaolo; Rosell, Rafael
Melanoma: oncogenic drivers and the immune system
2015-01-01 Karachaliou, Niki; Pilotto, Sara; Teixidó, Cristina; Viteri, Santiago; González Cao, María; Riso, Aldo; Morales Espinosa, Daniela; Molina, Miguel Angel; Chaib, Imane; Santarpia, Mariacarmela; Richardet, Eduardo; Bria, Emilio; Rosell, Rafael
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors
2015-01-01 Pilotto, Sara; Sperduti, I; Novello, S; Peretti, Umberto; Milella, M; Facciolo, F; Vari, S; Leuzzi, G; Vavalà, T; Marchetti, A; Mucilli, F; Crinò, L; Puma, F; Kinspergher, Stefania; Santo, A; Carbognin, L; Brunelli, Matteo; Chilosi, Marco; Scarpa, Aldo; Tortora, Giampaolo; Bria, Emilio
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma
2015-01-01 Bria, Emilio; Pilotto, Sara; Amato, Eliana; Fassan, M; Novello, S; Peretti, U; Vavalà, T; Kinspergher, S; Righi, L; Santo, A; Brunelli, Matteo; Corbo, Vincenzo; Gilioli, Eliana; Sperduti, I; Milella, M; Chilosi, Marco; Scarpa, Aldo; Tortora, Giampaolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research | 1-gen-2011 | Bonomi, M; Pilotto, Sara; Milella, M; Massari, F; Cingarlini, Sara; Brunelli, Matteo; Chilosi, Marco; Tortora, Giampaolo; Bria, Emilio | |
| Sorafenib for lung cancer: is the "Battle" still open ? | 1-gen-2012 | Bria, Emilio; Pilotto, Sara; Tortora, Giampaolo | |
| Clinical meta-analyses of targeted therapies in adenocarcinoma. | 1-gen-2013 | Bria, Emilio; Bonomi, M; Pilotto, Sara; Massari, F; Novello, S; Levra, Mg; Tortora, Giampaolo; Scagliotti, G. | |
| Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number. | 1-gen-2013 | Pilotto, Sara; Bria, Emilio; Peretti, U; Massari, F; Garassino, M; Pelosi, G; Tortora, Giampaolo | |
| Advances towards the design and development of personalized non-small-cell lung cancer drug therapy. | 1-gen-2013 | Vari, S.; Pilotto, Sara; Maugeri Saccà, M.; Ciuffreda, L.; Incani, U. C.; Falcone, I.; Curatolo, A. D.; Ceribelli, A.; Gelibter, A.; Maria, R. D.; Tortora, Giampaolo; Cognetti, F.; Bria, Emilio; Milella, M. | |
| Predictors of outcome for EGFR‑mutant non-small-cell lung cancer treated with first-line tyrosine kinase inhibitors. | 1-gen-2013 | Pilotto, S.; Bria, E. | |
| Neoplasie a sede primitiva ignota (Capitolo 18) | 1-gen-2013 | Bria, Emilio; Massari, F; Pilotto, Sara; Maines, F; Tortora, Giampaolo | |
| PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine. | 1-gen-2013 | Pilotto, Sara; Peretti, U; Novello, S; Rossi, G; Milella, M; Giaj Levra, M; Ciuffreda, L; Massari, F; Brunelli, M; Tortora, Giampaolo; Bria, Emilio | |
| Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: A 'Hard Days Night' | 1-gen-2014 | Pilotto, Sara; Bonomi, M; Massari, F; Milella, M; Ciuffreda, L; Brunelli, Matteo; Fassan, M; Chilosi, Marco; Scarpa, Aldo; Tortora, Giampaolo; Bria, Emilio | |
| Targeting the epidermal growth factor receptor in solid tumors: focus on safety. | 1-gen-2014 | Lucchini, E; Pilotto, Sara; Spada, E; Melisi, Davide; Bria, Emilio; Tortora, Giampaolo | |
| Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials | 1-gen-2014 | Bria, Emilio; Carbognin, L; Furlanetto, J; Pilotto, Sara; Bonomi, M; Guarneri, V; Vicentini, C; Brunelli, Matteo; Nortilli, R; Pellini, Francesca; Sperduti, I; Giannarelli, D; Pollini, Giovanni Paolo; Conte, P; Tortora, Giampaolo | |
| Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer. | 1-gen-2014 | Bria, Emilio; Di Modugno, F; Sperduti, I; Iapicca, P; Visca, P; Alessandrini, G; Antoniani, B; Pilotto, Sara; Ludovini, V; Vannucci, J; Bellezza, G; Sidoni, A; Tortora, Giampaolo; Radisky, Dc; Crinò, L; Cognetti, F; Facciolo, F; Mottolese, M; Milella, M; Nisticò, P. | |
| Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials | 1-gen-2014 | Pilotto, Sara; Di Maio, M; Peretti, U; Kinspergher, S; Brunelli, Matteo; Massari, F; Sperduti, I; Giannarelli, D; De Marinis, F; Tortora, Giampaolo; Bria, Emilio | |
| ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung | 1-gen-2014 | Caliò, A; Nottegar, Alessia; Gilioli, Eliana; Bria, Emilio; Pilotto, Sara; Peretti, U; Kinspergher, S; Simionato, F; Pedron, Serena; Knuutila, S; Tortora, Giampaolo; Eccher, Albino; Santo, A; Tondulli, L; Inghirami, G; Tabbò, F; Martignoni, Guido; Chilosi, Marco; Scarpa, Aldo; Brunelli, Matteo | |
| High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers | 1-gen-2014 | Fassan, M; Simbolo, Michele; Bria, Emilio; Mafficini, A; Pilotto, Sara; Capelli, Paola; Bencivenga, M; Pecori, Sara; Luchini, Claudio; Neves, D; Turri, G; Vicentini, C; Montagna, Licia; Tomezzoli, Anna; Tortora, Giampaolo; Chilosi, Marco; DE MANZONI, Giovanni; Scarpa, Aldo | |
| Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers | 1-gen-2015 | Carbognin, Luisa; Pilotto, Sara; Milella, Michele; Vaccaro, Vanja; Brunelli, Matteo; Calio', Anna; Cuppone, Federica; Sperduti, Isabella; Giannarelli, Diana; Chilosi, Marco; Bronte, Vincenzo; Scarpa, Aldo; Bria, Emilio; Tortora, Giampaolo | |
| Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity | 1-gen-2015 | Pilotto, Sara; Molina Vila, Miguel Angel; Karachaliou, Niki; Carbognin, Luisa; Viteri, Santiago; González Cao, Maria; Bria, Emilio; Tortora, Giampaolo; Rosell, Rafael | |
| Melanoma: oncogenic drivers and the immune system | 1-gen-2015 | Karachaliou, Niki; Pilotto, Sara; Teixidó, Cristina; Viteri, Santiago; González Cao, María; Riso, Aldo; Morales Espinosa, Daniela; Molina, Miguel Angel; Chaib, Imane; Santarpia, Mariacarmela; Richardet, Eduardo; Bria, Emilio; Rosell, Rafael | |
| Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors | 1-gen-2015 | Pilotto, Sara; Sperduti, I; Novello, S; Peretti, Umberto; Milella, M; Facciolo, F; Vari, S; Leuzzi, G; Vavalà, T; Marchetti, A; Mucilli, F; Crinò, L; Puma, F; Kinspergher, Stefania; Santo, A; Carbognin, L; Brunelli, Matteo; Chilosi, Marco; Scarpa, Aldo; Tortora, Giampaolo; Bria, Emilio | |
| Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma | 1-gen-2015 | Bria, Emilio; Pilotto, Sara; Amato, Eliana; Fassan, M; Novello, S; Peretti, U; Vavalà, T; Kinspergher, S; Righi, L; Santo, A; Brunelli, Matteo; Corbo, Vincenzo; Gilioli, Eliana; Sperduti, I; Milella, M; Chilosi, Marco; Scarpa, Aldo; Tortora, Giampaolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile